- ICH GCP
- Amerikanska kliniska prövningsregistret
- Klinisk prövning NCT07531264
EMG-ledd Neuro-Muskulär Koordinationsförbättring (NICE) Rehabilitering Genom Människa-Maskin Interaktion (NICE)
Neuro-Muskulär Koordinationsförbättrande (NICE) Rehabilitering
Studieöversikt
Status
Betingelser
Intervention / Behandling
Detaljerad beskrivning
Stroke är den främsta orsaken till svår långvarig funktionsnedsättning och drabbar 9,4 miljoner amerikaner. Varje år drabbas cirka 800 000 personer av stroke även i USA. Kronisk motorisk funktionsnedsättning i övre extremitet är en viktig bidragande faktor till funktionsnedsättning; funktionell användning av den drabbade övre extremiteten i vardagslivet är en nyckelfaktor för ökad självständighet, återgång till arbete och övergripande livskvalitet. Därför är effektiv och innovativ behandling för att adressera långvarig funktionsnedsättning både ett stort folkhälsomässigt behov och en ekonomisk nödvändighet.
Studien kommer att utveckla en innovativ människa-maskin-interaktionsplattform för att rikta in sig på och förbättra interledskoordination och motorisk funktion genom att förbättra muskelkoordination i övre extremiteten. I denna studie kommer totalt 38 personer med kronisk stroke att slumpmässigt fördelas till två rehabiliteringsstrategier: neuromuskulärkoordinationsstyrd träning (NICE; terapi-grupp) eller kraftstyrd träning (kontrollgrupp). Inklusionskriterierna består främst av: (1) haft en ischemisk eller hemorragisk stroke minst 6 månader tidigare (kronisk stroke); (2) vara mellan 21 och 80 år gammal; (3) inte ha fått botulinumtoxinbehandling i den drabbade armen under de senaste 3 månaderna; och (4) inte ha några kognitiva nedsättningar som skulle påverka uppgiftsförståelse eller förmåga att ge informerat samtycke.
Denna studie kommer att utvärdera effekterna av båda rehabiliteringsövningarna på muskelkoordination, standardiserade kliniska poäng, kinetik och elektroencefalogram.
Studietyp
Inskrivning (Beräknad)
Fas
- Tidig fas 1
Kontakter och platser
Studiekontakt
- Namn: Jinsook Roh, PhD
- Telefonnummer: 7137432578
- E-post: jroh@Central.UH.EDU
Studieorter
-
-
Texas
-
Houston, Texas, Förenta staterna, 77045
- University of Houston
-
Kontakt:
- JIN-SOOK ROH, PhD
- Telefonnummer: 6173680050
- E-post: jsroh@central.uh.edu
-
Huvudutredare:
- Jinsook Roh, PhD
-
-
Deltagandekriterier
Urvalskriterier
Åldrar som är berättigade till studier
- Vuxen
- Äldre vuxen
Tar emot friska volontärer
Beskrivning
Inklusionskriterier:
- Ischemisk eller hemorragisk stroke
- Ålder mellan 21 och 80 år
- Inte fått botulinumtoxin på den drabbade armen inom 3 månader
- MAS ≤ 3 runt armbåge och axel
Exklusionskriterier:
- har en ortopedisk störning som involverar övre extremiteter;
- kognitiv nedsättning som är tillräcklig för att störa informerat samtycke eller lyckad genomförande av protokollet (Montreal Cognitive Assessment (MoCA) poäng ≤ 26);
- en historia av en annan neurologisk sjukdom;
- anestesi av ledpositionssinne i övre extremiteter;
- är gravida eller har en chans att de kan vara det (självrapporterat);
Studieplan
Hur är studien utformad?
Designdetaljer
- Primärt syfte: Behandling
- Tilldelning: Randomiserad
- Interventionsmodell: Parallellt uppdrag
- Maskning: Trippel
Vapen och interventioner
Deltagargrupp / Arm |
Intervention / Behandling |
|---|---|
|
Experimentell: Neuromuscular coordination enhancement (NICE) intervention
Post-stroke participants will perform a center-out task by activating individual motor modules (generating coordinated isometric contractions of muscles) to move the cursor on a screen while electromyographic (EMG) signals are recorded.
Activation of each muscle (or muscle group) will be mapped to 1 of 4 directions within the multi-dimensional cursor space.
We will derive the cursor position in real time using Motor module activation magnitudes recorded from arm muscles.
|
Neuro-Intermuscular Coordination Enhancement (NICE) is a motor module-guided rehabilitation intervention designed to improve upper-extremity motor recovery after stroke by retraining impaired intermuscular coordination patterns. Participants perform isometric upper-extremity force-generation tasks using a human-machine interface while receiving real-time visual feedback derived from motor module recruitment signals calculated from surface electromyography (EMG). Individualized motor module targets are derived from the participant's less-affected upper extremity and used to guide selective recruitment of impaired coordination patterns in the more-affected upper extremity. Participants will complete 18 one-hour training sessions over six weeks (3 sessions/week). During training, participants perform repetitive target-matching tasks that require preferential recruitment of specific motor modules while minimizing unintended activation of non-target modules. |
|
Aktiv komparator: EMG-amplitude biofeedback exercise
Participants will perform a center-out target matching tasks where individual muscle EMGs are used to move a cursor on the visual feedback display to match one of 4 different targets presented to them.
Here, just the EMG amplitude, and not the coordination is focused on.
|
EMG Amplitude Biofeedback Exercise is an active comparator rehabilitation intervention designed to improve upper-extremity motor function after stroke through targeted muscle activation training.
Participants perform isometric upper-extremity exercises using a human-machine interface with real-time EMG amplitude-based visual feedback.
Individualized muscle activation targets derived from the less-affected upper extremity guide training of the more-affected upper extremity.
Participants will complete 18 one-hour sessions over 6 weeks (3 sessions/week).
|
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Fugl-Meyer Assessment (FMA) score
Tidsram: Baseline, six- week, 10-week, and 18-week follow-ups.
|
Motor impairment after stroke will be measured by upper extremity FMA (UE-FMA).
The maximum UE-FMA motor score is 66 (i.e., 0: complete motor impairment; 66: normal motor performance).
Each item is scored on a 3-point scale (0 = cannot perform, 1 = performs partially, 2 = performs fully).
The FMA score reflects the level of upper extremity motor impairment.
|
Baseline, six- week, 10-week, and 18-week follow-ups.
|
Sekundära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Similarity Score of Intermuscular Coordination Patterns (or Motor Modules)
Tidsram: Baseline, six- week, 10-week, and 18-week follow-ups.
|
Surface EMGs will be recorded from 8 key arm muscles during a 54-target isometric force generation task.
A dimensionality reduction method (non-negative matrix factorization (NNMF)) will be applied to identify intermuscular coordination patterns - operational definition of motor modules in the field of motor neuroscience.
They are mathematically 8-dimensional unit vectors.
Similarity score is the scalar product (or dot product) between a pair of intermuscular coordination patterns in comparison (i.e., motor modules).
We compute the similarity score between the less-affected and the more-affected arms.
Also, surface EMGs will be recorded from 8 key arm muscles during 3D dynamic reaching tasks.
NNMF will be applied to EMGs to identify and compare intermuscular coordination patterns.
Similarity score is the scalar product between motor modules (i.e., intermuscular coordination patters) of the more-affected arm in stroke group and dominant arm in healthy group.
|
Baseline, six- week, 10-week, and 18-week follow-ups.
|
|
Kinematic Synergy Similarity Score
Tidsram: Baseline, six-week, 10-week, and 18-week follow-ups.
|
Kinematic synergies are a representation of multi-joint coordination.
It will be identified using NNMF algorithm applied to the joint kinematic data obtained from 3D dynamic point-to-point reaching tasks.
Kinematic synergy similarity between stroke and healthy will be calculated using their scalar product.
|
Baseline, six-week, 10-week, and 18-week follow-ups.
|
|
Pairwise joint angle-to-angle correlation value
Tidsram: Baseline, six- week, 10-week, and 18-week follow-ups.
|
Pairwise joint angle-to-angle correlation is a way to see the joint coupling using kinematic data.
It will be calculated using Pearson's correlation coefficient between joint angles during the point-to-point reaching task.
|
Baseline, six- week, 10-week, and 18-week follow-ups.
|
|
Active range of motion
Tidsram: Baseline, six-week, 10-week, and 18-week follow-ups.
|
The active range of motion will be calculated from full active range tasks for shoulder flexion/extension, internal/external rotation, abduction/adduction, elbow flexion/extension, and wrist pronation/supination. Kinematic joint positions and angles will be used to calculate the same.
|
Baseline, six-week, 10-week, and 18-week follow-ups.
|
|
EEG Spectral power ratios
Tidsram: Baseline and six-week follow-up.
|
EEG-derived spectral power ratios will be calculated, in resting and task conditions, across different frequency bands (delta, theta, alpha, beta, gamma) and different events (onset, successful match, etc.) across four different directions of target match.
|
Baseline and six-week follow-up.
|
|
EEG-derived Brain Symmetry Index
Tidsram: Baseline and six-week follow-up.
|
The revised brain symmetry index with EEG signals will be computed in the resting state during eyes open and closed conditions.
|
Baseline and six-week follow-up.
|
|
Cortico-muscular connectivity
Tidsram: Baseline and six-week follow-up.
|
Functional connectivity using a directed transfer function will be computed to identify the information flow and coherence among EEG and EMG signals in the desired brain region and muscle activation associated with directional 4-target isometric force generation.
|
Baseline and six-week follow-up.
|
|
Cortico-cortical connectivity
Tidsram: Baseline and six-week follow-up.
|
Functional connectivity using a directed transfer function will be computed to identify the information flow and coherence among EEG signals from different regions of interest (sources, e.g., ipsi and contralesional fronto-parietal regions, primary motor cortex and somatosensory cortices).
|
Baseline and six-week follow-up.
|
Andra resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Participant recruitment rate
Tidsram: From participant recruitment beginning to enrollment completion
|
Recruitment rate will be calculated as the number of participants enrolled per month during the recruitment period.
This is a feasibility outcome.
|
From participant recruitment beginning to enrollment completion
|
|
Participant intervention adherence
Tidsram: Throughout the 6-week intervention period.
|
Intervention adherence will be calculated as the percentage of scheduled intervention sessions completed by each participant.
This is a feasibility outcome.
|
Throughout the 6-week intervention period.
|
|
Participant Tolerance of the Intervention
Tidsram: Throughout the 6-week intervention period.
|
Participant tolerance will be measured as the number and percentage of participants who complete intervention sessions without stopping due to discomfort, fatigue, pain, or other intolerance-related reasons.
This is a feasibility outcome.
|
Throughout the 6-week intervention period.
|
|
Intervention fidelity
Tidsram: Throughout the 6-week intervention period.
|
Intervention fidelity will be calculated as the percentage of intervention sessions delivered according to the study protocol.
This is a feasibility outcome.
|
Throughout the 6-week intervention period.
|
|
Dose equivalence between the intervention groups
Tidsram: Throughout the 6-week intervention period.
|
Dose equivalence will be assessed by comparing total intervention dose between groups, measured as total minutes of training and/or number of completed sessions per participant.
This is a feasibility outcome.
|
Throughout the 6-week intervention period.
|
|
NICE-specific training feasibility
Tidsram: Throughout the 6-week intervention period.
|
NICE-specific feasibility will be assessed as the percentage of NICE intervention sessions in which the NICE training system/protocol is successfully implemented as intended.
This is a feasibility outcome.
|
Throughout the 6-week intervention period.
|
|
Participant retention rate
Tidsram: Baseline, six-week, 10-week, and 18- week follow-ups and throughout the 6-week intervention period.
|
Retention rate will be calculated as the percentage of enrolled participants who complete each scheduled follow-up assessment.
This is a feasibility outcome.
|
Baseline, six-week, 10-week, and 18- week follow-ups and throughout the 6-week intervention period.
|
|
Successful acquisition of study data
Tidsram: Baseline, six-week, 10-week, and 18- week follow-ups and throughout the 6-week intervention period.
|
Successful data acquisition will be calculated as the percentage of expected EMG, EEG, kinematic, and clinical outcome datasets successfully collected and usable for analysis.
This is a feasibility outcome.
|
Baseline, six-week, 10-week, and 18- week follow-ups and throughout the 6-week intervention period.
|
|
Box and Block Test (BBT) score
Tidsram: Baseline, six-week follow-up, and 10-week follow-up. Keeping a 18-week follow-up as an exploratory time point.
|
The gross manual dexterity and upper extremity coordination will be assessed through BBT, which involves transfer of blocks from one compartment of a box to the other within 60 seconds.
The score is the number of blocks successfully transferred to the other side within 60 seconds.
|
Baseline, six-week follow-up, and 10-week follow-up. Keeping a 18-week follow-up as an exploratory time point.
|
|
Modified Ashworth Scale (MAS) score
Tidsram: Baseline, six-week follow-up, and 10-week follow-up. Keeping a 18-week follow-up as an exploratory time point.
|
The increase in muscle tone will be assessed through MAS around the elbow and shoulder.
MAS score ranges from 0 to 5. The MAS score reflects the severity of muscle spasticity.
|
Baseline, six-week follow-up, and 10-week follow-up. Keeping a 18-week follow-up as an exploratory time point.
|
|
Wolf Motor Function Test (WMFT) score
Tidsram: Baseline, six-week follow-up, and 10-week follow-up. Keeping a 18-week follow-up as an exploratory time point.
|
Motor function will be assessed through WMFT, which evaluates both the time and quality of performance across 17 tasks that range from simple joint movements to complex functional activities (like lifting a can or folding a towel).
Performance Time (sec) is measured, with a maximum time limit (usually 120 seconds).
Functional Ability Scale rates the quality of movement, using a 6-point ordinal scale (0 = Does not attempt with the involved arm, 1 = Attempted but cannot complete task, 2 = Completes task with great difficulty or poor movement quality, 3 = Completes task with moderate difficulty or noticeable impairment, 4 = Completes task with minor difficulty or near-normal movement, 5 = Normal movement quality and speed).
The WMFT score assesses upper extremity motor function.
|
Baseline, six-week follow-up, and 10-week follow-up. Keeping a 18-week follow-up as an exploratory time point.
|
Samarbetspartners och utredare
Sponsor
Utredare
- Huvudutredare: Jinsook Roh, PhD, University of Houston
Publikationer och användbara länkar
Allmänna publikationer
- Roh J, Cheung VC, Bizzi E. Modules in the brain stem and spinal cord underlying motor behaviors. J Neurophysiol. 2011 Sep;106(3):1363-78. doi: 10.1152/jn.00842.2010. Epub 2011 Jun 8.
- Dewald JP, Sheshadri V, Dawson ML, Beer RF. Upper-limb discoordination in hemiparetic stroke: implications for neurorehabilitation. Top Stroke Rehabil. 2001 Spring;8(1):1-12. doi: 10.1310/WA7K-NGDF-NHKK-JAGD.
- Nordin AD, Hairston WD, Ferris DP. Faster Gait Speeds Reduce Alpha and Beta EEG Spectral Power From Human Sensorimotor Cortex. IEEE Trans Biomed Eng. 2020 Mar;67(3):842-853. doi: 10.1109/TBME.2019.2921766. Epub 2019 Jun 13.
- Roh J, Beer RF, Lai A, Rho M, Karvelas KR, Nader AM, Kendall MC, Rymer WZ. The Effects of Selective Muscle Weakness on Muscle Coordination in the Human Arm. Appl Bionics Biomech. 2018 Sep 19;2018:5637568. doi: 10.1155/2018/5637568. eCollection 2018.
- Park JH, Lee H, Kwon HJ, Shin JH, Roh J, Park HS. Feasibility of Isokinetic Training to Modify Coupling of Upper Limb Muscle Synergy Activation in Stroke-affected Upper Limb. Annu Int Conf IEEE Eng Med Biol Soc. 2023 Jul;2023:1-4. doi: 10.1109/EMBC40787.2023.10339985.
- Portilla-Jimenez M, Seo G, Houston M, Hong YNG, Li S, Park HS, Zhang Y, Roh J. Improving impaired intermuscular coordination after stroke through synergy-guided human-machine interaction: a pilot study. Annu Int Conf IEEE Eng Med Biol Soc. 2024 Jul;2024:1-4. doi: 10.1109/EMBC53108.2024.10782001.
- Seo G, Park JH, Park HS, Roh J. Developing new intermuscular coordination patterns through an electromyographic signal-guided training in the upper extremity. J Neuroeng Rehabil. 2023 Sep 1;20(1):112. doi: 10.1186/s12984-023-01236-2.
- Seo G, Kishta A, Mugler E, Slutzky MW, Roh J. Myoelectric interface training enables targeted reduction in abnormal muscle co-activation. J Neuroeng Rehabil. 2022 Jul 1;19(1):67. doi: 10.1186/s12984-022-01045-z.
- Li S. Stroke Recovery Is a Journey: Prediction and Potentials of Motor Recovery after a Stroke from a Practical Perspective. Life (Basel). 2023 Oct 15;13(10):2061. doi: 10.3390/life13102061.
Användbara länkar
Studieavstämningsdatum
Studera stora datum
Studiestart (Beräknad)
Primärt slutförande (Beräknad)
Avslutad studie (Beräknad)
Studieregistreringsdatum
Först inskickad
Först inskickad som uppfyllde QC-kriterierna
Första postat (Faktisk)
Uppdateringar av studier
Senaste uppdatering publicerad (Faktisk)
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senast verifierad
Mer information
Termer relaterade till denna studie
Ytterligare relevanta MeSH-villkor
Andra studie-ID-nummer
- STUDY00001333-NICE
Plan för individuella deltagardata (IPD)
Planerar du att dela individuella deltagardata (IPD)?
Läkemedels- och apparatinformation, studiedokument
Studerar en amerikansk FDA-reglerad läkemedelsprodukt
Studerar en amerikansk FDA-reglerad produktprodukt
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .